Further reknowned Speakers for the SCC2025 Symposium confirmed
Today we confirm additional Experts for SCC 2025: Courtney D. DiNardo, Simon Haas and Mirco Friedrich.
More reknowned Speakers confirmed
We are thrilled to announce additional distinguished speakers for SCC2025, taking place from September 14-16, 2025, at DKFZ in Heidelberg. Experts such as Cedric Blanpain, Salvador Aznar Benitah, Ann-Kathrin Eisfeld, Andreas Trumpp, and keynote speaker Scott Armstrong will contribute to discussions on stem cell research and cancer. Ross L. Levine will join on September 16, providing further insights into hematologic malignancies. Stay tuned for more updates as we enhance the symposium’s program with esteemed speakers.
2025 First reknowned Speakers confirmed
We are pleased to announce the confirmed speakers for the 12th International Heidelberg Symposium on Stem Cells and Cancer (SCC2025), taking place on September 14-15, 2025, at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. Esteemed experts such as Carsten Müller-Tidow, Ross L. Levine, Scott Armstrong, Catriona Jamieson, Paresh Vyas, and keynote speaker Elaine Fuchs will share their insights on advancements in stem cell research and cancer. Their participation promises to foster collaborations and drive innovation in research and clinical applications.
The next SCC international symposium 2023
The 11th International Heidelberg Symposium on Stem Cells and Cancer (SCC2023) will be held from September 10-12, 2023, at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. This biennial event brings together leading experts to discuss the latest advancements in stem cell research and cancer. Highlights include presentations from renowned speakers such as Scott Armstrong and Ross Levine, as well as an AML Clinical Workshop focusing on innovative strategies to target acute myeloid leukemia.
AML clinical workshop 2023
The 11th International Heidelberg Symposium on Stem Cells and Cancer (SCC2023), held from September 10-12, 2023, at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, featured an AML Clinical Workshop focusing on novel approaches to target leukemic stem cells and overcome therapy resistance.
Impressions from previous years
Five short stories about stem cells and cancer